Pam_Garzone.jpg

Pamela D. Garzone, Ph.D.

BOARD MEMBER

EDUCATION

M.Sc. | University of Pittsburgh, Pharmacy

Ph.D. | University of Pittsburgh, Clinical Science

B.Sc | Purdue, Pharmacy

LinkedIn

Pamela D. Garzone is a respected pharmaceutical executive with a significant record of achievement in drug development and leadership, ascending to the C-suite. She has led teams successfully through the regulatory process, culminating in clearance of multiple INDs in different therapeutic areas and approval of registration dossiers. Pamela is valued as an authentic leader, providing inspiration and motivation, mediating conflict resolution and chief influencer of executive management. She has interacted with health authorities (US, CHMP, PMDA, HC) for pre-IND meetings, EOP2 meetings, FDA advisory committees, and EMEA scientific advice meetings. Pamela is an invited speaker at international meetings and for prominent organizations as well as an author of peer reviewed scientific articles. Recognized for her strategic, scientific, and regulatory leadership in drug development, she serves as advisor to executives of start-up and clinical stage biotechnology companies, venture capitalists and non-profit research foundations and as the co-chair of AIM-HI Women’s Venture Competition. She has extensive experience helping boards and committees achieve aggressive goals and fulfill key objectives. In recognition of her expertise, she is on the Scientific Advisory Boards of two early-stage biotechnology companies and the Asian Fund for Cancer Research. Pamela is currently the Chief Development Officer of Anixa Biosciences.